On 12 Nov 2026 Colgate-Palmolive closed at $97.90, +26.9% this year; market cap $78.22bn, P/E 38.1.
Consumer Staples · Household Products · NYSE · United States
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
| Market cap | $78.22bn |
| P/E (trailing) | 38.1 |
| EPS (TTM) | $2.57 |
| Beta | 0.31 |
| Dividend | $2.12 |
| Dividend yield | 2.17% |
| Ex-dividend date | 20 Oct 2026 |
| Latest report | 30 Oct 2026 |
| Next earnings | 29 Jan 2027 |
| YTD | +26.9% |
| 1Y | +27.6% |
| 3Y | +11.4% |
| 5Y | +7.2% |
| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $20.38bn | $2.13bn | $3.63bn |
| 2024 | $20.10bn | $2.89bn | $3.55bn |
| 2023 | $19.46bn | $2.30bn | $3.04bn |
| 2022 | $17.97bn | $1.78bn | $1.86bn |
| 2021 | $17.42bn | $2.17bn | $2.76bn |
We publish no single base value for Colgate-Palmolive. Our valuation methods put it between $76.80 and $117.28 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate. See every method
Call and put prices: our price for each next to the market's.
Open in the dashboard · Run a full Desk Run
Data as of 12 Nov 2026. Not investment advice.